FDA Inspection 1023839 — Syntactx Core Laboratory
The FDA completed an inspection of Syntactx Core Laboratory on Aug 2, 2017 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 2, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional details
Sponsor, Contract Research Organization